AESCA Pharma GmbH   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Traiskirchen Austria (1946)
Status: Left NME R&D (2017)

Organization Overview

First Clinical Trial
2005
NCT00266812
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now